Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women
Journal of Cancer Treatment and Research · 23.09.2025 · 13 (3) · 83-90
DOI: 10.11648/j.jctr.20251303.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cancer Treatment and Research, online erschienen am 23.09.2025. Verfasst von Mamady Keita und 9 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Introduction: recurrence after treatment for uterine cervical cancer is not uncommon, and its management is a major challenge for the clinician. The aim of this study was to determine the maximum tolerated dose and dose-limiting toxicity of weekly chemotherapy combined with postoperative radiotherapy for uterine cervical cancer. Material and methods : Chinese women with localised uterine cervical cancer were recruited between 2017 and 2020. Pelvic radiotherapy (6 -10 MV X-rays, IMRT 40-45 Gy / 20 fractions, boost of 10-20 Gy/ 5-10fractions on parameters) was followed by brachytherapy ( 192 Ir, 10 - 20Gy/2-4fractions). Weekly chemotherapy was initiated with 20 mg/m 2 cisplatin and 10mg/m 2 paclitaxel. The 5 + 5 approach to escalate the dose for each 5 patients until the dose-limiting toxicity level was reached was used. Results : a total of 30 patients aged 32-78 years were included. Two out of 5 patients in the dose level 5 group developed grade 3 diarrhoea after 4 weeks. One patient in dose level 4 and 6 developed grade 4 leukopenia and neutropenia, respectively. There were no cases of delayed chemotherapy. With a median follow-up of 64.5 months, 3 patients died after recurrence of metastases. Conclusion : cisplatin - paclitaxel combined with postoperative radiotherapy has been shown to be highly effective and safe in Chinese women with localised uterine cervical cancer. The dose-limiting toxicities are 35 mg/m 2 cisplatin and 30 mg/m 2 paclitaxel per week for at least 6 cycles.
Zitieren
APA
Keita, M., Xi, C., Camara, A., Balde, A., Cisse, K., Conde, I., Toure, A., Bah, M., Traore, B., & Liu, H. (2025). Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women. Journal of Cancer Treatment and Research, 13(3), 83-90. https://doi.org/10.11648/j.jctr.20251303.16
Vancouver
Keita M, Xi C, Camara A, Balde A, Cisse K, Conde I, et al. Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women. Journal of Cancer Treatment and Research. 2025;13(3):83-90. doi:10.11648/j.jctr.20251303.16
BibTeX
@article{Keita2025,
author = {Keita, Mamady and Xi, Chen and Camara, Abou and Balde, Arbaba and Cisse, Kalil and Conde, Ibrahima and Toure, Alhassane and Bah, Malick and Traore, Bangaly and Liu, Hong},
title = {Localised Cervical Cancer: Impact of Weekly Chemotherapy and Postoperative Radiotherapy in Chinese Women},
journal = {Journal of Cancer Treatment and Research},
year = {2025},
volume = {13},
number = {3},
pages = {83--90},
doi = {10.11648/j.jctr.20251303.16}
}
EUVIMED